A new University of Memphis office building and a new Dunkin' are among the projects seeking new commercial construction permits in the Memphis area.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Strengthened Leadership and Expanded U.S. Presence Positions SynOx for Regulatory Filings and Commercialization of Emactuzumab for Tenosynovial Giant Cell Tumours (TGCT) DUBLIN, Ireland and OXFORD, ...

As of December 31, 2024, Fortress’ consolidated cash and cash equivalents totaled $57.3 million, compared to $58.9 million as of September 30, 2024, and $80.9 million as of December 31, 2023, a ...

Occupier acquisitions increased 32% last year, a CBRE report found, and the trend contributed to industrial property values ...

Plus Therapeutics shares are trading higher by 244% during Thursday's session. The company announced that the FDA accepted the name REYOBIQ for the company's lead asset. The ‘Trade of the Day ...

The UK government are 'really keen' on getting Man United's new stadium 'off the ground' and remain confident that the project will go ahead. Man United announced plans last week to build a brand ...

Manchester United have confirmed plans to leave Old Trafford and move to a new 100,000-seater stadium. The new stadium, which will be the largest in the UK, will be built on club-owned land ...

Let’s dig into the relative performance of Biogen (NASDAQ:BIIB) and its peers as we unravel the now-completed Q4 therapeutics earnings season. Over the next few years, therapeutic companies ...